Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 181200 of 20,252 grants

Active NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

ADMINISTRATIVE CORE – ABSTRACT To support the mission of the Advancing Cancer Control Equity Research Through Transformative Solutions in Patient Navigation (ACCERT PN) Center as a...

Active NON-SBIR/STTR RPGS
Research Methods, Measures, and Data Management Core
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

RESEARCH METHODS, MEASURES AND DATA MANAGEMENT CORE – ABSTRACT The Advancing Cancer Control Equity Research Through Transformative Solutions in Patient Navigation Center (ACCERT PN...

Active NON-SBIR/STTR RPGS
Advancing Innovations in Patient Navigation and Implementation Science to Address Structural Racism and Social Determinants of Health
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

SOCIAL DETERMINANTS OF HEALTH RESEARCH PROJECT – ABSTRACT Cancer is a leading cause of death in Chicago, and Black, Latinx and low-income Chinese communities in Chicago face signif...

Active NON-SBIR/STTR RPGS
Advancing Cancer Control Equity Research Through Transformative Solutions in Patient Navigation - Community Responsive Projects
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

COMMUNITY RESPONSIVE PROJECTS – ABSTRACT Community Responsive Projects within the Advancing Cancer Control Equity Research Through Transformative Solutions in Patient Navigation (A...

Active OTHER RESEARCH-RELATED
The Gut Microbial and Dietary Origins of Cancer Treatment-Related CognitiveImpairment
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2024 – 2026

During chemotherapy, 34% of breast cancer survivors (BCS) experience cancer treatment-related cognitive impairment (CRCI). CRCI degrades memory and executive function as well as qu...

$1.51M
USD
Active NON-SBIR/STTR RPGS
Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar Rhabdomyosarcoma
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Fusion-positive alveolar rhabdomyosarcoma (FP-RMS) remains a poorly understood but highly fatal cancer of childhood. The pathognomonic fusion oncoprotein o...

$23.27M
USD
Active SBIR-STTR RPGS
Antigen-targeted activation of Topo1 inhibitors via click chemistry
NATIONAL CANCER INSTITUTE Shasqi, Inc United States 2024 – 2026

Abstract Most drugs are administered systemically and spread throughout the body. Due to lack of specificity for the pathological site, high doses are required to achieve effective...

$15.68M
USD
Active NON-SBIR/STTR RPGS
Reducing prostate cancer mortality in African American men by early disease detection using DNA fragmentation profiles and methylated DNA patterns of plasma derived cell free DNA
NATIONAL CANCER INSTITUTE Boston Children'S Hospital United States 2024 – 2026

Project Summary/Abstract: African American (AA) individuals with prostate cancer (PCa) face significantly worse clinical outcome than their European American (EA) counterparts. The...

$4.76M
USD
Active NON-SBIR/STTR RPGS
Remote, Young Adult Lay-Counselor Delivered Behavioral and Digital Intervention for Youth to Promote Vaping Cessation and Prevent Escalation of Tobacco Use
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT While tobacco smoking has declined dramatically among adolescents and is now almost rare, the prevalence of electronic nicotine delivery device (ENDS, nico...

$8.49M
USD
Active NON-SBIR/STTR RPGS
Interrogating the role of arachidonic acid metabolism in modulating the tumor immune microenvironment as a novel path to therapeutic intervention
NATIONAL CANCER INSTITUTE University of South Florida United States 2024 – 2029

ABSTRACT Cancer has been characterized as a chronic, poorly healing wound where inflammatory and proliferative processes continue unchecked without normal healing and resolution of...

$6.25M
USD
Active NON-SBIR/STTR RPGS
Supporting Cancer Research as a Core-based Scientist by Providing Comprehensive Genetically Engineered Rodent Model Services
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2029

Project Summary/Abstract To conquer cancer, researchers with diverse backgrounds and expertise must work together to discover molecular targets and develop therapeutics. Many inves...

$1.43M
USD
Active NON-SBIR/STTR RPGS
Southeast Center for Health Achievement and Growth in Equity (SEACHANGE) Hub
NATIONAL CANCER INSTITUTE University of Mississippi Med Ctr United States 2024 – 2029

ABSTRACT The mission of the SouthEAst Center for Health Achievement aNd Growth in Equity (SEACHANGE) Hub is to promote health equity and reduce the burden of disease in underserved...

$9.49M
USD
Active NON-SBIR/STTR RPGS
Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2024 – 2028

PROJECT SUMMARY Cancer-related fatigue is one of the most common and debilitating toxicities/side effects stemming from cancer and its treatments. Patients who endure hematologic m...

$3.76M
USD
Active SBIR-STTR RPGS
Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer
NATIONAL CANCER INSTITUTE Manzanita Pharmaceuticals, Inc United States 2024 – 2026

ABSTRACT Translational safety studies in novel nerve imaging agent for radical prostatectomies In this two-year proposal, we will complete IND-enabling studies for NerveLight, a ne...

$9.06M
USD
Active SBIR-STTR RPGS
Advancing the commercialization readiness of nanoparticle-based immunotherapy for cancer treatment
NATIONAL CANCER INSTITUTE Pdx Pharmaceuticals, Inc United States 2024 – 2026

Treatment of non-small cell lung cancer (NSCLC) requires a combination of many highly toxic drugs and radiation therapy, yet the 5-year survival rate remains about 18%. Immune chec...

$1.61M
USD
Active NON-SBIR/STTR RPGS
Evaluating a Multilevel Intervention to Increase Colonoscopic Follow-up after Abnormal Stool-based Colorectal Cancer Screening in a Community Safety-Net Setting
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2029

Project Summary/Abstract Colorectal cancer (CRC) is the second most common cause of cancer-related mortality in the United States (U.S.). Although several effective prevention and...

$6.23M
USD
Active NON-SBIR/STTR RPGS
FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trial
NATIONAL CANCER INSTITUTE University of Chicago United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Lynch syndrome (LS), the most common inherited cause of colorectal cancer (CRC) affecting ~1.2 million Amer- icans, carries 3-8x higher lifetime CRC risk t...

$7.02M
USD
Active NON-SBIR/STTR RPGS
A Multi-level Intervention to Reduce Total Thyroidectomy Overuse for Low-Risk Cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

PROJECT SUMMARY The majority of patients with low-risk thyroid cancer undergo total thyroidectomy – the riskiest treatment option. Safer, less invasive alternatives offer patients...

$3.57M
USD
Active RESEARCH CENTERS
Disparities in Immuno-oncology Outcomes in Detroit (DIODE)
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2026

Project Summary This application will address cancer health disparities in Black residents of metropolitan Detroit, specifically evaluating racial differences in genetic regulation...

$3.52M
USD
Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2026

Project Summary The overall goals of this P20 application are (1) to identify ancestry-specific genetic regulators of macrophage function and response to anti-HER2 antibody therapy...